Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.

Leukemia & lymphoma - 1 Jan 2016

Zhou Jing-dong, Yang Jing, Guo Hong, Deng Zhao-qun, Wen Xiang-mei, Yang Lei, Yin Jia-yu, Xiao Gao-fei, Lin Jiang, Qian Jun

Abstract excerpt

To investigate DLX4 isoforms expression and their clinical significance in acute myeloid leukemia (AML). DLX4 transcript variant 1 (BP1) expression was significantly up-regulated in AML patients compared with normal controls. However, DLX4 transcript variant 2 (DLX7) was significantly down-regulated in AML patients. Both in the overall AML and the non-M3 AML cohorts, those patients with high BP1 expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Line, Tumor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Chromosome Aberrations

Share to Gene Expression

Share to Homeodomain Proteins

Share to Leukemia, Myeloid, Acute

Share to RNA Isoforms

Share to ROC Curve

Source

Identifiers

PMID: 26325005
DOI: 10.3109/10428194.2015.1088648

Genes

DLX4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BP1 overexpression is associated with adverse prognosis in de novo acute myeloid leukemia.PMID 26325005Read ↗

DLX4 hypermethylation is a prognostically adverse indicator in de novo acute myeloid leukemia.Semantic proximity Read ↗

AML1/RUNX1 Mutations in 470 Adult Patients with De Novo Acute Myeloid Leukemia: Prognostic Implication and Interaction with Other Gene Alterations.Semantic proximity Read ↗

Clinical features and long-term outcomes of pediatric patients with de novo acute myeloid leukemia in China with or without specific gene abnormalities: a cohort study of patients treated with BCH-AML 2005.Semantic proximity Read ↗

Low expression of MN1 associates with better treatment response in older patients with de novo cytogenetically normal acute myeloid leukemiaSemantic proximity Read ↗

Prognostic significance of WT1 gene expression at diagnosis in adult de novo acute myeloid leukemiaSemantic proximity Read ↗

Higher HOPX expression is associated with distinct clinical and biological features and predicts poor prognosis in de novo acute myeloid leukemiaSemantic proximity Read ↗

Identification and validation of prognosis‐related DLX5 methylation as an epigenetic driver in myeloid neoplasmsSemantic proximity Read ↗

PTBP1 is a potential indicator of disease progression in acute myeloid leukemia.Semantic proximity Read ↗

Refinement of Risk-Stratification of Cytogenetically Normal Acute Myeloid Leukemia Adult Patients by MN1 Expression.Semantic proximity Read ↗

FBXW4 Is Highly Expressed and Associated With Poor Survival in Acute Myeloid LeukemiaSemantic proximity Read ↗

Epigenetic inactivation of DLX4 is associated with disease progression in chronic myeloid leukemiaSemantic proximity Read ↗

LncRNA CD27-AS1 promotes acute myeloid leukemia progression through the miR-224-5p/PBX3 signaling circuitSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.